Novartis AG Net Worth 2006-2018 | NVS

Interactive chart of historical net worth (market cap) for Novartis AG (NVS) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Novartis AG net worth as of February 20, 2019 is $209.61B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $209.609B $51.900B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $365.814B 16.67
Pfizer (PFE) United States $251.211B 14.07
Merck (MRK) United States $214.158B 18.30
Eli Lilly (LLY) United States $127.004B 22.06
Novo Nordisk (NVO) Denmark $121.443B 19.64
AbbVie (ABBV) United States $120.322B 10.11
Sanofi (SNY) France $105.716B 13.05
AstraZeneca (AZN) United Kingdom $102.658B 11.71
GlaxoSmithKline (GSK) United Kingdom $102.598B 13.47
Bristol-Myers Squibb (BMY) United States $83.732B 12.89